Adverse Drug Reaction Classification System

Pharmaceutical Information
Drug Name Hydrocortisone cypionate
Drug ID BADD_D01089
Description Not Available
Indications and Usage For the relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses. Also used to treat endocrine (hormonal) disorders (adrenal insufficiency, Addisons disease). It is also used to treat many immune and allergic disorders, such as arthritis, lupus, severe psoriasis, severe asthma, ulcerative colitis, and Crohn's disease.
Marketing Status Discontinued
ATC Code A01AC03; A07EA02; C05AA01; D07AA02; D07XA01; H02AB09; S01BA02; S01CB03; S02BA01
DrugBank ID DB14541
KEGG ID D00976
MeSH ID C029109
PubChem ID 223253
TTD Drug ID Not Available
NDC Product Code Not Available
Synonyms hydrocortisone cypionate | hydrocortisone 21-cyclopentylpropionate
Chemical Information
Molecular Formula C29H42O6
CAS Registry Number 508-99-6
SMILES CC12CCC(=O)C=C1CCC3C2C(CC4(C3CCC4(C(=O)COC(=O)CCC5CCCC5)O)C)O
Chemical Structure
ADR Related Proteins Induced by Drug
ADR Term Protein Name UniProt AC TTD Target ID PMID
Not AvailableNot AvailableNot AvailableNot AvailableNot Available
ADRs Induced by Drug
ADR Term ADReCS ID ADR Frequency (FAERS) ADR Severity Grade (FAERS) ADR Severity Grade (CTCAE)
Abdominal distension07.01.04.001--
Alanine aminotransferase increased13.03.01.003--
Alkalosis hypokalaemic14.01.02.002--Not Available
Aspartate aminotransferase increased13.03.01.006--
Benign intracranial hypertension17.07.02.001--Not Available
Cardiac failure congestive02.05.01.002--Not Available
Cataract subcapsular06.06.01.002--Not Available
Cushingoid24.08.02.004; 19.07.03.001; 14.11.01.006; 05.01.01.002--
Ecchymosis24.07.06.002; 23.06.01.001; 01.01.03.001--Not Available
Erythema23.03.06.001--Not Available
Exophthalmos06.09.04.001; 05.02.02.002--Not Available
Fluid retention20.01.02.003; 14.05.06.002--Not Available
Glaucoma06.03.01.002--
Headache17.14.01.001--
Hyperhidrosis23.02.03.004; 08.01.03.028--
Hypertension24.08.02.001--
Hypokalaemic syndrome14.05.03.003--Not Available
Hypothalamo-pituitary disorder05.03.04.003--Not Available
Impaired healing08.03.02.001--Not Available
Intracranial pressure increased17.07.02.002--Not Available
Intraocular pressure increased13.07.04.002--Not Available
Menstruation irregular05.05.01.008; 21.01.01.005--
Muscle disorder15.05.03.014--Not Available
Muscular weakness15.05.06.001; 17.05.03.005--
Myopathy15.05.05.001--Not Available
Nitrogen balance negative13.13.01.010--Not Available
Osteonecrosis24.04.05.004; 15.02.04.007--
Osteoporosis15.02.03.002; 14.04.04.002--
Pancreatitis07.18.01.001--
Papilloedema24.03.07.001; 17.07.02.004; 06.09.02.002--
The 1th Page    1 2    Next   Last    Total 2 Pages